Coronary drug-eluting stent development: issues in trial design.
Publication
, Journal Article
Muni, NI; Califf, RM; Foy, JR; Boam, AB; Zuckerman, BD; Kuntz, RE
Published in: Am Heart J
March 2005
Duke Scholars
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
March 2005
Volume
149
Issue
3
Start / End Page
415 / 433
Location
United States
Related Subject Headings
- Stents
- Research Design
- Recurrence
- Product Surveillance, Postmarketing
- Pharmacokinetics
- Models, Animal
- Maximum Tolerated Dose
- Humans
- Equipment Design
- Drug Delivery Systems
Citation
APA
Chicago
ICMJE
MLA
NLM
Muni, N. I., Califf, R. M., Foy, J. R., Boam, A. B., Zuckerman, B. D., & Kuntz, R. E. (2005). Coronary drug-eluting stent development: issues in trial design. Am Heart J, 149(3), 415–433. https://doi.org/10.1016/j.ahj.2004.09.001
Muni, Neal I., Robert M. Califf, Jonette R. Foy, Ashley B. Boam, Bram D. Zuckerman, and Richard E. Kuntz. “Coronary drug-eluting stent development: issues in trial design.” Am Heart J 149, no. 3 (March 2005): 415–33. https://doi.org/10.1016/j.ahj.2004.09.001.
Muni NI, Califf RM, Foy JR, Boam AB, Zuckerman BD, Kuntz RE. Coronary drug-eluting stent development: issues in trial design. Am Heart J. 2005 Mar;149(3):415–33.
Muni, Neal I., et al. “Coronary drug-eluting stent development: issues in trial design.” Am Heart J, vol. 149, no. 3, Mar. 2005, pp. 415–33. Pubmed, doi:10.1016/j.ahj.2004.09.001.
Muni NI, Califf RM, Foy JR, Boam AB, Zuckerman BD, Kuntz RE. Coronary drug-eluting stent development: issues in trial design. Am Heart J. 2005 Mar;149(3):415–433.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
March 2005
Volume
149
Issue
3
Start / End Page
415 / 433
Location
United States
Related Subject Headings
- Stents
- Research Design
- Recurrence
- Product Surveillance, Postmarketing
- Pharmacokinetics
- Models, Animal
- Maximum Tolerated Dose
- Humans
- Equipment Design
- Drug Delivery Systems